Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial

Journal of Infection (2023) - Comments
doi: 10.1016/j.jinf.2022.12.003 issn: 0163-4453 pubmed: 36509358

Suad Hannawi, Linda Saifeldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Jian Li, Yuanxin Chen, Liangzhi Xie